Simvastatin Reduces Adiponectin Levels and Insulin Sensitivity
Completed
- Conditions
- Hypercholesterolemia
- Registration Number
- NCT00546182
- Lead Sponsor
- Gachon University Gil Medical Center
- Brief Summary
We hypothesized simvastatin may reduce adiponectin levels and insulin sensitivity in overweight hypercholesterolemic patients.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
- Low-density lipoprotein cholesterol levels more than 100 and body mass index more than 23.0
Exclusion Criteria
- Patients with overt liver disease
- Chronic renal failure
- Hypothyroidism, myopathy
- Uncontrolled diabetes
- Severe hypertension, stroke
- Acute coronary events
- Coronary revascularization within the preceding 3 months, or
- Alcohol abuse.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method simvastatin may reduce adiponectin levels and insulin sensitivity in overweight hypercholesterolemic patients
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Gil Medical Center, Gachon University
🇰🇷Incheon, Korea, Republic of